A rating of 82 puts Adaptimmune Therapeutics PLC - ADR (ADAP) near the top of the Biotechnology industry according to InvestorsObserver. Adaptimmune Therapeutics PLC - ADR's score of 82 means it scores higher than 82% of stocks in the industry. Adaptimmune Therapeutics PLC - ADR also received an overall rating of 68, putting it above 68% of all stocks. Biotechnology is ranked 21 out of the 148 industries.
ADAP has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ADAP!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Adaptimmune Therapeutics PLC - ADR Stock Today?
Adaptimmune Therapeutics PLC - ADR (ADAP) stock is trading at $1.36 as of 1:07 PM on Thursday, Mar 21, a rise of $0.02, or 1.88% from the previous closing price of $1.33. The stock has traded between $1.29 and $1.40 so far today. Volume today is below average. So far 697,099 shares have traded compared to average volume of 1,850,969 shares.
Click Here to get the full Stock Report for Adaptimmune Therapeutics PLC - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter